LakeShore Biopharma Co., Ltd. (LSB) - Dilution Analysis

Visualizing historical and potential share dilution over time

View Stock Details

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Dilution Analysis

Low Risk

Limited dilution potential

Last updated: July 31, 2025

Risk Assessment Details

Potential Dilution: 0.0% of current shares

Recent Dilution: 0% (2 years)

Historical Dilution Factor: minimal recent dilution

Outstanding Shares

21M

Potential Supply

Additional shares possible

Splits

None

Past 2 years

Summary

LSB currently has 20.8M outstanding shares. with minimal authorized share overhang for future dilution. The company has not diluted shareholders through share issuances in the past 2 years, which is positive for existing holders.

Share Structure Timeline

Outstanding Shares

Total Supply

Historical Data Points

Date	Event	Outstanding	Supply
Jul 31, 2025	20-F filing \| 20.8M shares outstanding	21M	0
Aug 15, 2024	20-F filing \| 190.2M shares outstanding	190M	0
Jan 23, 2024	POS AM filing: This POS AM filing registers for resale up to 24,130,762 Ordinary Shares by the Selling Securityholders named in the prospectus.	93M	0
Aug 08, 2023	POS AM filing: This is a POS AM filing for the resale of up to 24,130,762 Ordinary Shares by Selling Securityholders.	93M	0
Jul 26, 2023	20-F filing \| 93.1M shares outstanding	93M	24M
Apr 12, 2023	F-1 filing: This F-1 filing registers the resale of up to 24,130,762 ordinary shares by selling securityholders.	93M	24M

Back to LSB Details